- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06196112
Localization of Vasculonervous Structures in Tibial Nerve Neuromodulation: a Cross-sectional Study
Study Overview
Status
Conditions
Detailed Description
Design: A cross-sectional observational study at the Physiotherapy Unit of the Ramón y Cajal University Hospital.
The main objective of this study is to determine the location and size of tibial vasculonervous structures (nerve, artery, and vein) in relation to the tibia and skin using ultrasound in healthy subjects Methods: Healthy subjects will participate, and sociodemographic data (age, sex, weight, height) will be collected. Subsequently, various measurements of the right tibial vasculonervous structures will be obtained through ultrasound A single examiner with over 5 years of experience in ultrasound will perform the measurements.
Significance of the research: Knowledge of the position and size of the tibial vasculonervous bundle could be useful to justify and standardize transcutaneous and percutaneous approaches in tibial nerve neuromodulation. This would improve the safety of the technique, avoiding adverse events resulting from the intervention
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28034
- Hospital Universitario Ramon y Cajal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy subjects over 18 years of age
Exclusion Criteria:
- Previous fracture of the distal end of the right tibia
- Previous vascular pathology of the distal end of the right tibia
- Previous nervous condition of the distal end of the right tibia
- Previous surgical intervention of the distal end of the right tibia
- Ongoing oncological process of the distal end of the right tibia
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tibial Distance (TD) to the tibial nerve
Time Frame: Day 1
|
Subjects will be placed in a right lateral decubitus position on a bed. Seven marks will be made with a dermal marker from the lower edge of the right tibial malleolus, following the medial edge of the tibial bone in the cranial direction. Measurements will be taken at 2, 4, 5, 6, 8, 10, and 12 cm with respect to the lower edge of the tibial malleolus. The most superficial aspect of the tibia will be considered for the measurements. The measurements will be performed using an ultrasound machine (ALPINIONⓒ, Seoul, South Korea, model ECUBE 8LEⓇ) with a linear probe L3-12T (frequency range 3-12 MHz), using the Rehabilitative Ultrasound Imaging (RUSI) method. The distance will be measured using a caliper by drawing a straight line from the most medial aspect of the tibia to the most anterior aspect of the nerve, taking into consideration the outer edge of the tibial nerve wall. This will be analyzed at each of the 7 marks previously described |
Day 1
|
|
Tibial Distance (TD) to the tibial artery
Time Frame: Day 1
|
Subjects will be placed in a right lateral decubitus position on a bed. Seven marks will be made with a dermal marker from the lower edge of the right tibial malleolus, following the medial edge of the tibial bone in the cranial direction. Measurements will be taken at 2, 4, 5, 6, 8, 10, and 12 cm with respect to the lower edge of the tibial malleolus. The most superficial aspect of the tibia will be considered for the measurements. The measurements will be performed using an ultrasound machine (ALPINIONⓒ, Seoul, South Korea, model ECUBE 8LEⓇ) with a linear probe L3-12T (frequency range 3-12 MHz), using the Rehabilitative Ultrasound Imaging (RUSI) method. The distance will be measured using a caliper by drawing a straight line from the most medial aspect of the tibia to the most anterior aspect of the artery, taking into consideration the outer edge of the tibial artery wall. This will be analyzed at each of the 7 marks previously described |
Day 1
|
|
Tibial Distance (TD) to the tibial vein
Time Frame: Day 1
|
Subjects will be placed in a right lateral decubitus position on a bed. Seven marks will be made with a dermal marker from the lower edge of the right tibial malleolus, following the medial edge of the tibial bone in the cranial direction. Measurements will be taken at 2, 4, 5, 6, 8, 10, and 12 cm with respect to the lower edge of the tibial malleolus. The most superficial aspect of the tibia will be considered for the measurements. The measurements will be performed using an ultrasound machine (ALPINIONⓒ, Seoul, South Korea, model ECUBE 8LEⓇ) with a linear probe L3-12T (frequency range 3-12 MHz), using the Rehabilitative Ultrasound Imaging (RUSI) method. The distance will be measured using a caliper by drawing a straight line from the most medial aspect of the tibia to the most anterior aspect of the vein, taking into consideration the outer edge of the tibial vein wall. This will be analyzed at each of the 7 marks previously described |
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Horizontal Tibial Distance to the tibial nerve
Time Frame: Day 1
|
The horizontal distance will be collected by drawing a perpendicular line with the caliper from the most medial aspect of the tibia to the most anterior aspect of the nerve, taking into consideration the outer edge of the tibial nerve wall.
The measurement will be taken at each of the 7 marks previously described.
This measurement will allow for an extrapolation in the implementation of percutaneous techniques
|
Day 1
|
|
Horizontal Tibial Distance to the tibial artery
Time Frame: Day 1
|
The horizontal distance will be collected by drawing a perpendicular line with the caliper from the most medial aspect of the tibia to the most anterior aspect of the artery tibial, taking into consideration the outer edge of the tibial artery wall.
The measurement will be taken at each of the 7 marks previously described.
This measurement will allow for an extrapolation in the implementation of percutaneous techniques
|
Day 1
|
|
Horizontal Tibial Distance to the tibial vein
Time Frame: Day 1
|
The horizontal distance will be collected by drawing a perpendicular line with the caliper from the most medial aspect of the tibia to the most anterior aspect of the vein, taking into consideration the outer edge of the tibial vein wall.
The measurement will be taken at each of the 7 marks previously described.
This measurement will allow for an extrapolation in the implementation of percutaneous techniques
|
Day 1
|
|
Depth of the tibial nerve
Time Frame: Day 1
|
Using the ultrasound machine and considering a caliper perpendicular from the most superficial aspect of the skin to the most superficial aspect of the epineurium at each of the 7 previously described marks
|
Day 1
|
|
Cross-sectional area of the tibial nerve
Time Frame: Day 1
|
The cross-sectional area of the nerve will be measured at each of the 7 marks described above using the ultrasound
|
Day 1
|
|
Cross-sectional area of the tibial artery
Time Frame: Day 1
|
The cross-sectional area of the artery will be measured at each of the 7 marks described above using the ultrasound
|
Day 1
|
|
Cross-sectional area of the tibial vein
Time Frame: Day 1
|
The cross-sectional area of the vein will be measured at each of the 7 marks described above using the ultrasound
|
Day 1
|
|
Overlap between each structure
Time Frame: Day 1
|
The overlap between the tibial nerve, artery, and vein will be described at each of the 7 marks previously mentioned
|
Day 1
|
|
Variability of the tibial vessels
Time Frame: Day 1
|
The number of arteries and veins present will be recorded at each of the 7 marks previously described
|
Day 1
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 115/23
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.